| AAV | Adeno-associated virus | 
| AC | Adenocarcinoma | 
| ACTS | Adoptive T-cell therapies | 
| AHR | Aryl hydrocarbon receptor | 
| AIF | Apoptosis inducible factor | 
| AIM-2 | Absent in melanoma-2 | 
| AMP | Antimicrobial peptides | 
| APC | Antigen-presenting cell | 
| BECs | Basal epithelial cells | 
| CAC | Cervical adenocarcinoma | 
| CAR-T cell | Chimeric antigen receptor T cell | 
| CC | Cervical cancer | 
| CECs | Cervical epithelial cells | 
| cGAMP | Cyclic GMP-AMP | 
| cGAS | cGMP-AMP synthase | 
| CIN | Cervical intraepithelial neoplasia | 
| CLR | C-type lectin receptors | 
| CMI | Cell-mediated immunity | 
| CTL | Cytotoxic T lymphocyte | 
| DNAM-1 | DNAX accessory molecule-1 | 
| DGE | Differential gene expression | 
| FoxP3 | Forkhead box protein P3 | 
| FRT | Female reproductive tract | 
| HIF | Hypoxia-inducible factor | 
| HR-HPV | High-risk HPV | 
| hTERT | Human telomeres reverse transcriptase | 
| ICIs | Immune checkpoint inhibitors | 
| IDO | Indolamine dioxygenase | 
| LCs | Langerhans cells | 
| MAIT | Mucosal-associated invariant T | 
| MIP | Macrophage inflammatory protein | 
| MUC | Mucin | 
| NET | Neutrophil extracellular trap | 
| NKCC | NK-cell-mediated toxicity | 
| NKG2D | Natural killer group 2D | 
| NLR | Neutrophil lymphocyte ratio | 
| NOD | Nucleotide-binding oligomerization domain | 
| PRR | Pattern-recognition receptor | 
| RGS | Regulator of G protein signaling | 
| RICK | RIP-like interacting CLARP kinase | 
| SCC | Squamous cell carcinoma | 
| SIL | Squamous intraepithelial lesion | 
| STING | Stimulating interferon genes | 
| TCR | T-cell receptor | 
| TCR-T cells | TCR-engineered/modified effector T cells | 
| TDO | Tryptophan dioxygenase | 
| TIME | Tumor immune microenvironment | 
| TME | Tumor microenvironment | 
| TGF-β | Transforming growth factor beta | 
| TSLP | Thymic stromal lymphopoietin | 
| TZ | Transformational Zone | 
| VISTA | V-domain immunoglobulin suppressor of T cell activation |